CAVIN1 and COVID-19: Although there is no definitive evidence of a mechanistic relationship of PTRF and T2DM, we hypothesize that downregulation of PTRF after COVID-19 convalescence may lead to symptoms of AGL, thus increasing the risk of T2DM.